Advantan® 0

DRUG2 trials

Sponsors

Aco Hud Nordic AB, Dermapharm AG

Conditions

Mild to moderate atopic dermatitisatopic dermatitis/eczema

Phase 1

Double-blind, randomised clinical study comparing efficacy and safety of Methylprednisolone Aceponate 0.1% Ointment (Test) vs. Advantan® 0.1% Ointment (Reference) vs. Vehicle in patients with mild to moderate atopic dermatitis

RecruitingCTIS2024-514548-10-01

Dermapharm AGMild to moderate atopic dermatitis

Start: 2021-07-26Target: 330Updated: 2025-12-03

Phase 4

A phase IV randomised, double-blind, parallel-design, controlled multi-center trial of a NOVel moisturiser for Atopic dermatitis: effect on relapse prevention in children, NOVA II

CompletedCTIS2022-501184-41-00

Aco Hud Nordic ABatopic dermatitis/eczema

Start: 2023-02-13End: 2024-05-02Target: 270Updated: 2023-10-23